Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
bristol-myers squibb
clinical trials
genfit
gilead sciences
life sciences
madrigal pharmaceuticals
nash
2
×
national blog main
national top stories
new york blog main
new york top stories
nonalcoholic steatohepatitis
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
viking therapeutics
aducanumab
affordable care act
aldeyra therapeutics
alex azar
allergan
alzheimer's disease
bayer
biogen
boulder/denver blog main
boulder/denver top stories
brammer bio
celgene
clinical data
deals
detroit blog main
detroit top stories
eisai
elicio therapeutics
federal trade commission
galapagos nv
hookipa pharma
What
drug
nash
2
×
aducanumab
alzheimer’s
amyloid
angst
approved
bagged
billions
bio
biogen
biogen’s
brammer
data
disease
effects
failure
fatty
felt
horizon
intercept
known
liver
lost
marketed
medicine
new
news
nonalcoholic
ripple
roundup
steatohepatitis
track
week
Language
Current search:
nash
×
nash
×
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug